SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Veradigm Inc. - MDRXPRNewsWire • 12/18/23
ROSEN, A LEADING NATIONAL FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MDRXPRNewsWire • 12/16/23
MDRX ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit against Veradigm Inc. (MDRX)PRNewsWire • 12/15/23
IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the FirmAccesswire • 12/14/23
Veradigm Inc. Announces that Nasdaq Hearings Panel has Granted its Continued Listing, Pending Return to Compliance with Nasdaq Filing RequirementsBusiness Wire • 12/13/23
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Veradigm Inc. (MDRX) Investors and Encourages Investors to Contact the Firm Before January 22, 2024Business Wire • 12/13/23
MDRX ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Veradigm Inc.Business Wire • 12/12/23
Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Veradigm Inc.PRNewsWire • 12/12/23
Veradigm to Enhance Independent Practice Financial Management with AI for Practice Fusion Billing ServicesBusiness Wire • 12/11/23
Veradigm Inc. (MDRX) Investors with Large Losses Should Contact Robbins LLP for Information About Their Rights and RemediesBusiness Wire • 12/07/23
ROSEN, A RANKED AND LEADING FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MDRXPRNewsWire • 12/07/23
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the FirmAccesswire • 12/07/23
FINAL DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses of $100,000 to Contact the FirmAccesswire • 12/06/23
VERADIGM SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their OptionsPRNewsWire • 12/05/23
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses In Excess of $100,000 to Contact the FirmAccesswire • 12/05/23
IMPORTANT INVESTOR DEADLINE: The Schall Law Firm Reminds Investors in Veradigm Inc. with Losses In Excess of $100,000 to Contact the FirmAccesswire • 12/04/23
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Veradigm Inc. (MDRX)Business Wire • 12/01/23
IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses of $100,000 to Contact the FirmAccesswire • 12/01/23
Veradigm Inc. Investors Should Contact Robbins LLP for Information About Our Investigation of MDRXBusiness Wire • 11/30/23
MDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Veradigm Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Business Wire • 11/30/23
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Veradigm Inc. (MDRX)Business Wire • 11/30/23
VERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Veradigm To Contact Him Directly To Discuss Their OptionsPRNewsWire • 11/30/23
DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses of $100,000 to Contact the FirmAccesswire • 11/30/23
ROSEN, A LEADING LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - MDRXPRNewsWire • 11/30/23
